Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...
The current public-health risk is low, but the CDC is working with states to monitor people with animal exposure.
The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect ...
The package will provide additional support for late-stage development and licensure of pre-pandemic mRNA-based vaccines, the ...
The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country ...
Given the uncertainty regarding its top-line growth, we would advise short-term investors to steer clear of MRNA stock.
Moderna receives $590M contract from HHS for mRNA-based bird flu vaccine; up 4% in after-hours trading. Read more here.
The version of the virus spreading in North America right now has led to only a few serious cases, but concerns have been ...
Shares of Moderna (NASDAQ:MRNA) jumped 5% following reports that it had been awarded $590 million for the development of a ...
Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the development of mRNA-based pandemic influenza vaccines. The ...
US health officials announced Friday they were awarding $590 million to Moderna to develop mRNA vaccines against influenza, including advancing the company's bird flu vaccine, as fears of a new ...
Moderna (MRNA) announced ongoing support from the U.S. Department of Health and Human Services, HHS, to accelerate the development of ...